DE2259004A1 - Alkylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate - Google Patents

Alkylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Info

Publication number
DE2259004A1
DE2259004A1 DE2259004A DE2259004A DE2259004A1 DE 2259004 A1 DE2259004 A1 DE 2259004A1 DE 2259004 A DE2259004 A DE 2259004A DE 2259004 A DE2259004 A DE 2259004A DE 2259004 A1 DE2259004 A1 DE 2259004A1
Authority
DE
Germany
Prior art keywords
radical
general formula
hydrogen
alkylamine derivatives
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2259004A
Other languages
German (de)
English (en)
Inventor
Shigeho Inaba
Shigenari Katayama
Isamu Maruyama
Masaru Nakao
Keiichi Ono
Kikuo Sasajima
Masahuru Takayama
Yoshihiro Tanaka
Hisao Yamamoto
Izumi Yanagihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2259004A1 publication Critical patent/DE2259004A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE2259004A 1971-12-03 1972-12-01 Alkylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate Pending DE2259004A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46097939A JPS5761750B2 (enrdf_load_stackoverflow) 1971-12-03 1971-12-03

Publications (1)

Publication Number Publication Date
DE2259004A1 true DE2259004A1 (de) 1973-06-20

Family

ID=14205621

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2259004A Pending DE2259004A1 (de) 1971-12-03 1972-12-01 Alkylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Country Status (10)

Country Link
US (1) US3925387A (enrdf_load_stackoverflow)
JP (1) JPS5761750B2 (enrdf_load_stackoverflow)
BE (1) BE792187A (enrdf_load_stackoverflow)
CA (1) CA997764A (enrdf_load_stackoverflow)
CH (1) CH575926A5 (enrdf_load_stackoverflow)
DE (1) DE2259004A1 (enrdf_load_stackoverflow)
FR (1) FR2162168B1 (enrdf_load_stackoverflow)
GB (1) GB1411583A (enrdf_load_stackoverflow)
NL (1) NL7216334A (enrdf_load_stackoverflow)
SE (1) SE395693B (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477778A3 (en) * 1990-09-25 1992-08-19 Eisai Co., Ltd. Benzene, pyridine and pyrimidine derivative
US5462958A (en) * 1992-07-20 1995-10-31 Eisai Co., Ltd. Benzene derivatives and method of treating arteriosclerosis with benzene derivatives
WO1999050247A1 (en) * 1998-03-31 1999-10-07 Acadia Pharmaceuticals, Inc. Compounds with activity on muscarinic receptors
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017624A (en) * 1973-02-05 1977-04-12 Sumitomo Chemical Company, Limited N-(ω-Amino)alkylaniline derivatives
JPS5922704B2 (ja) * 1974-08-13 1984-05-28 住友化学工業株式会社 新規なアシルヒドラゾン誘導体及びその塩の製法
US4051248A (en) * 1975-07-14 1977-09-27 E. R. Squibb & Sons, Inc. 1,3,8-triazaspiro(4.5)decan-4-one derivatives
JPS56126422U (enrdf_load_stackoverflow) * 1980-02-14 1981-09-26
JPS56115769A (en) * 1980-02-18 1981-09-11 Tanabe Seiyaku Co Ltd Piperazine derivative and its preparation
JPS57175581U (enrdf_load_stackoverflow) * 1981-04-29 1982-11-06
FR2761064B1 (fr) * 1997-03-20 1999-06-04 Pf Medicament Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments
PE20000728A1 (es) * 1998-06-26 2000-08-21 Cocensys Inc Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda
WO2018139237A1 (ja) 2017-01-25 2018-08-02 国立研究開発法人産業技術総合研究所 画像処理方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633914A (enrdf_load_stackoverflow) * 1962-06-22
FR1535403A (fr) * 1962-12-26 1968-08-09 Abbott Lab Procédé de préparation d'éthers et de thio-éthers aromatiques de pipérazines n-substituées
BE628766A (enrdf_load_stackoverflow) * 1962-12-26
US3345364A (en) * 1964-05-06 1967-10-03 Janssen Pharmaceutica Nv Benzimidazolinyl piperidines
US3577422A (en) * 1968-04-10 1971-05-04 Abbott Lab 4-(omega-(4-(2-,or 3-halo-p-tolyl) - 1-piperazinyl) alkoxy) - beta,beta - dimethylhydrocinnamic acid esters
CA967965A (en) * 1968-12-24 1975-05-20 Hoffmann-La Roche Limited Aromatic ethers and process for the manufacture thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477778A3 (en) * 1990-09-25 1992-08-19 Eisai Co., Ltd. Benzene, pyridine and pyrimidine derivative
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
US5462958A (en) * 1992-07-20 1995-10-31 Eisai Co., Ltd. Benzene derivatives and method of treating arteriosclerosis with benzene derivatives
WO1999050247A1 (en) * 1998-03-31 1999-10-07 Acadia Pharmaceuticals, Inc. Compounds with activity on muscarinic receptors
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7485651B2 (en) 1998-03-31 2009-02-03 Acadia Pharmaceuticals, Inc. Compounds with activity on muscarinic receptors

Also Published As

Publication number Publication date
BE792187A (fr) 1973-03-30
CH575926A5 (enrdf_load_stackoverflow) 1976-05-31
SE395693B (sv) 1977-08-22
FR2162168A1 (enrdf_load_stackoverflow) 1973-07-13
GB1411583A (en) 1975-10-29
JPS5761750B2 (enrdf_load_stackoverflow) 1982-12-25
US3925387A (en) 1975-12-09
JPS4861482A (enrdf_load_stackoverflow) 1973-08-28
CA997764A (en) 1976-09-28
FR2162168B1 (enrdf_load_stackoverflow) 1975-11-28
NL7216334A (enrdf_load_stackoverflow) 1973-06-05

Similar Documents

Publication Publication Date Title
CH656383A5 (de) 2-(4-(4-(4,4-dialkyl-2,6-piperidindion-1-yl)-butyl)-1-piperazinyl)pyrimidine.
DE2541855A1 (de) 4-(polyalkoxy-phenyl)-2-pyrrolidone ii
DE2259004A1 (de) Alkylaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE3200304A1 (de) 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
EP0221376B1 (de) N-substituierte Diphenylpiperidine
DE2426149C3 (de) 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2646471A1 (de) 2- eckige klammer auf (substituierte piperazinyl-, piperidinyl- und tetrahydropyridinyl)-alkyl eckige klammer zu -2,3-dihydro-3-hydroxy-1h-benz eckige klammer auf d,e eckige klammer zu isochinolin-1-one, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE2264668A1 (de) Propenylaminderivate und verfahren zu dereb herstellung
CH652401A5 (de) Amino-2,1,3-benzothiadiazol- und -benzoxadiazol-derivate, ihre herstellung und sie enthaltende arzneimittel.
DE2425767A1 (de) 3-alkyl-9-aminoalkyl-1,2,3,4-tetrahydrocarbazole und ihre verwendung in arzneimitteln
DE2135172A1 (de) 2 Styrylchinazolindenvate und ihre Saureadditionsprodukte, Verfahren zum Her stellen solcher Substanzen und die daraus hergestellten Arzneimittel
DE2630588A1 (de) 3a,4,6,7-tetrahydro-3-phenyl-7-(phenylmethylen)-thiopyrano- eckige klammer auf 4,3-c eckige klammer zu pyrazol-2(3h)-alkylaminderivate, verfahren zu ihrer herstellung und arzneimittel
DE2423060A1 (de) Aminoderivate von pyrazolopyridinketonen
DE2139099C3 (de) l-Methyl-2-(p-methyl- a -phenylbenzyloxymethyl)piperidin, seine Salze mit Säuren und quartäre Ammoniumsalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
DE2905637C3 (de) 1,5-Benzothiazepin-Derivate
DE1795153A1 (de) Neue N-substituierte Piperidinspiroverbindungen,ihre Verwendung und Herstellung
DE1695080A1 (de) Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
DE2440541A1 (de) 1-piperidino- oder 1-pyrrolidino-3phenoxy-2-propanole, verfahren zu ihrer herstellung und arzneimittel
DE1695719C3 (de) Benzo eckige Klammer auf 1,2-h eckige Klammer zu -1,4-diazabicyclo eckige Klammer auf 4,4,0 eckige Klammer zu -decane und ein Verfahren zu ihrer Herstellung
AT276381B (de) Verfahren zur Herstellung von neuen Phenylisoindolderivaten und deren Salzen
DD150055A5 (de) Verfahren zur herstellung von neuen aminoisochinolinderivaten
DE2815840C3 (de) Quartäre Ammoniumverbindungen von p-Benzoyläthern und sie enthaltende Arzneimittel
AT217045B (de) Verfahren zur Herstellung von neuen monoalkylierten bzw. monohalogenierten N-Derivaten von 10,11-Dihydro-5H-dibenzo[b,f]azepinen und 5H-Dibenzo[b,f]azepinen
DE2635278A1 (de) 3,3a,4,5,6,7-hexahydro-3-phenyl-7 -phenylmethylen-2h-indazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1815450C (de) Spiro(4,5)decanverbindungen

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination